Home-time Is a Patient-Centered Outcome Variable for Stroke: An Executive Summary

Background An outcome measure to assess functional recovery after stroke that is easily obtainable and meaningful to the patient can be very useful for assessing risks and benefits of therapeutic strategies. Home-time, which is defined as the total number of days spent alive by the patient at home, outside healthcare institutions after discharge from an index stroke event, is an example of a patient-centered outcomemeasure that meets this need. The first known description of home-time as an outcome measure for stroke was noted in a study published in Stroke in 2008. In this study, home-time was demonstrated to be a robust and objective measure of poststroke recovery. In 2013, the Patient-Centered Outcomes Research Institute provided funding for a study entitled ‘‘PatientCentered Research into Outcomes Stroke Patient Prefer and Effectiveness Research’’ (PROSPER), which aimed to help patients, caregivers, and healthcare providers to make informed decisions regarding stroke care through comparative effectiveness research. Through qualitative work with patient partners, time spent at home after stroke was identified as a high-priority outcome. The home-time metric represents this value as an easy-tounderstand concept, defined and measurable in terms relevant to patients and their caregivers.

[1]  Eric E. Smith,et al.  Population-based study of home-time by stroke type and correlation with modified Rankin score , 2017, Neurology.

[2]  Eric E. Smith,et al.  Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research) , 2016, Stroke.

[3]  Eric E. Smith,et al.  Assessment of Home-Time After Acute Ischemic Stroke in Medicare Beneficiaries , 2016, Stroke.

[4]  Eric E. Smith,et al.  Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient‐Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study , 2015, Circulation.

[5]  Eric E. Smith,et al.  Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study , 2015, BMJ : British Medical Journal.

[6]  Emily C. O'Brien,et al.  Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care. , 2015, American heart journal.

[7]  Lesley Maisch,et al.  Certain uncertainty: life after stroke from the patient's perspective. , 2014, Circulation. Cardiovascular quality and outcomes.

[8]  Emily C. O'Brien,et al.  Clinical commentary on "Certain uncertainty: life after stroke from the patient's perspective". , 2014, Circulation. Cardiovascular quality and outcomes.

[9]  S. Warach,et al.  Standardizing the Structure of Stroke Clinical and Epidemiologic Research Data: The National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) Project , 2012, Stroke.

[10]  J. Grotta,et al.  Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy: A Validation Study of Home Time as an Outcome Measure , 2011, Stroke.

[11]  M. Walters,et al.  Time Spent at Home Poststroke: “Home-Time” a Meaningful and Robust Outcome Measure for Stroke Trials , 2008, Stroke.

[12]  Christopher J Weir,et al.  Comparison of the National Institutes of Health Stroke Scale With Disability Outcome Measures in Acute Stroke Trials , 2005, Stroke.

[13]  A. Dromerick,et al.  Sensitivity to changes in disability after stroke: a comparison of four scales useful in clinical trials. , 2003, Journal of rehabilitation research and development.

[14]  D. Wade,et al.  Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. , 2000, Stroke.